Adeno-Associated Virus (AAV) Vector Lot Release Package

Discover our lot release package for Adeno-Associated Virus (AAV) Vector, covering various assays to determine vector-specific characteristics, the presence of adventitious agents, residuals, and general characteristics. We conduct all testing in compliance with cGMP standards and offer custom assay development and validation services. With our new state-of-the-art facility, Rouse 400 (R400), in Philadelphia, PA, WuXi Advanced Therapies is fully equipped to handle lot release testing.

We have successfully supported over 140 Cell and Gene Therapy clients and have established strong relationships with regulatory agencies such as the EMA, TGA, Health Canada, and FDA. Our team of project managers and scientific experts are ready to assist with lot release and serve the target patient population. Stay ahead of the game and ensure the quality and safety of your AAV Vector lots with WuXi Advanced Therapies.